Med Tech & Devices
Medical technology transaction activity is supported by aging demographics, procedure volume growth, and strategic acquirers’ reliance on M&A to replenish product pipelines and enter adjacent categories.
Buyers include global medical-device strategics, diversified industrial and life-science companies, and private equity firms active in devices, components, and outsourced manufacturing. Premium valuations generally reflect proprietary technology, regulatory clearances, recurring consumables or service revenue, strong clinical evidence, and durable clinician preference. In a sale, buyers will closely evaluate intellectual property, regulatory and quality-system history, reimbursement dynamics, supplier concentration, engineering depth, and the scalability of manufacturing operations.
Focus areas
- Medical devices & instruments
- Consumables & single-use products
- Diagnostics & life-science tools
- Contract design & manufacturing
- Medical products & distribution
Featured deal
Has been acquired by
Avista Capital Partners